AstraZeneca: sell signal, week 6

Six weeks into the decline: momentum turns negative again this week

AstraZeneca is in week 6 of a sell signal with trading not recommended. This week momentum turned negative again after 3 sideways weeks: the technical picture remains mixed, with CMF in positive territory yet a weekly candle down 2.9%.

12 June 2026 · 43 min read min read

AstraZeneca · Sell signal under management

In Summary

AstraZeneca is in week 6 of a sell signal, with trading not recommended. After 3 sideways weeks, the price fell 2.9% this week and momentum turned sharply negative again. The technical picture remains mixed: capital flows have been positive for weeks, but the short-term structure is losing its grip. The case calls for observation, not new entries.

Ongoing decline ·6th week from start ·EU-UK stocks ·T2 ★ See Gold version →

IQS Phase

ordinary

Signal Strength

indecisive week

Sizing

MINIMUM

Ranking

#33 / 52

EU-UK stocks

Trade P&L %

+0.37%

from signal to today

Chart · Weekly — EMA50 · MACD · VWAP

Weekly chart · EMA50 · MACD · VWAP · Source: TradingView

How to read this pageA visual guide to the post, card by card→

The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM

restricted Platinum content